IGI Logo

Sun Pharmaceutical Industries is currently trading at Rs. 1847.95, up by 10.80 points or 0.59% from its previous closing of Rs. 1837.15 on the BSE.

The scrip opened at Rs. 1849.70 and has touched a high and low of Rs. 1853.55 and Rs. 1834.20 respectively. So far 16541 shares were traded on the counter.

The BSE group 'A' stock of face value Rs. 1 has touched a 52 week high of Rs. 1917.15 on 19-May-2026 and a 52 week low of Rs. 1547.25 on 26-Sep-2025.

Last one week high and low of the scrip stood at Rs. 1,853.55 and Rs. 1,792.80 respectively. The current market cap of the company is Rs. 444416.82 crore.

The promoters holding in the company stood at 54.48%, while Institutions and Non-Institutions held 37.03% and 8.48% respectively.

Sun Pharmaceutical Industries has entered into an agreement to acquire 100% outstanding shares of Innovcare Lifesciences. The deal is worth around Rs 271.2 crore. This strategic investment is aimed at strengthening the product portfolio of the company. The transaction is expected to be completed on or before July 31, 2026.

Innovcare Lifesciences is a company based in Mumbai and engaged in the business of marketing, distribution and sale of pharmaceutical drugs, nutraceutical and cosmeceutical products.